Navigation Links
China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
Date:2/22/2011

HONG KONG, Feb. 22, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company"), the first and largest cord blood banking operator in China, today announced the results of its 2010 Annual General Meeting, which was held on February 18, 2011, in Hong Kong.

At the Annual General Meeting, shareholders

  • elected Albert Chen and Mark Chen to serve on the Board of Directors until the 2013 annual general meeting of the Company or until their respective successors are duly appointed and qualified;

  • ratified the appointment of KPMG as auditor of the Company for the financial year ending March 31, 2011, and authorized the directors to set the remuneration of the auditors; and

  • adopted the 2011 China Cord Blood Corporation Restricted Share Unit Scheme, or the "Incentive Plan," which has a mandate limit of granting rights to receive ordinary shares not exceeding 10.0% of the Company's issued and outstanding share capital, to directors, officers, employees and/or consultants of the Company and its subsidiaries and authorize directors to grant awards and allot and issue shares thereunder.

  • About China Cord Blood CorporationChina Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.  For more information, please contact:China Cord Blood CorporationMs. Joeling LawTel:
    +852-3605-8180Email: ir@chinacordbloodcorp.comICR, LLCIn New York: Ashley M. AmmonTel: +1-646-277-1227In Beijing: Wen Lei ZhengTel: +86-10-6583-7510
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results
    2. China-Biotics to Report Fiscal Year 2011 Third Quarter Financial Results on February 9
    3. China-Biotics, Inc. Provides Preliminary FY2011Third Quarter Revenue
    4. Reportlinker Adds Industrial Biotechnology China News 1011
    5. Reportlinker Adds Financial Health of Biotechnology and Drugs Industry in India and China
    6. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011
    7. China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011
    8. China Cord Blood Corporation Announces Completion of Warrant Exchange
    9. China-Biotics Announces Redemption of $25 million in Senior Convertible Notes
    10. China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
    11. PRA International Expert to Speak at China Drug Safety Summit
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/23/2017)... ... 23, 2017 , ... The Academy of Model Aeronautics (AMA), ... Association (UAA), the unifying voice for collegiate aviation education, are launching a joint ... and success through a STEM-based education platform. , Much like the program currently ...
    (Date:6/22/2017)... , ... June 21, 2017 , ... ... office in North Carolina, and engages Timothy Reinhardt to manage the new site. ... leadership at Pfizer Inc, with his most recent role as the Director of ...
    (Date:6/22/2017)... ... June 22, 2017 , ... ... specialists DST Diagnostische Systeme & Technologien GmbH, thereby expanding its product portfolio to ... from hay fever, urticaria, asthma, atopic eczema or a food allergy. Allergies are ...
    (Date:6/22/2017)... ... June 22, 2017 , ... For the months ... produced a Spotlight series on “Cell Therapy Regulation” for its regenerative ... experts on the unique regulatory challenges of stem cell medical research. , Stem ...
    Breaking Biology Technology:
    (Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
    (Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
    (Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
    Breaking Biology News(10 mins):